Cure Parkinson’s and Alzheimer’s Research UK announce a partnership
Cure Parkinson’s and Alzheimer’s Research UK are working on an initiative that could pave the way for innovative neurodegenerative treatments. There is a growing recognition that tackling neurodegenerative diseases could benefit from a collaborative, cross-disease approach. We are recognising the overlap in underlying biological...
Learn more
2022 Tom Isaacs Award pays tribute to Drs. Michael Okun and Ray Dorsey
Cure Parkinson’s and Van Andel Institute (VAI) are delighted to announce Dr Ray Dorsey, University of Rochester, and Dr Michael Okun, University of Florida, are joint winners of the 2022 Tom Isaacs Award.
Phase 1 trial results of new GDNF delivery mechanism
The results of a recent clinical trial testing a new way of delivering the nerve growth factor, GDNF, into the brains of people with Parkinson’s demonstrate that it is safe and well tolerated. Glial cell-line derived neurotrophic factor, or GDNF as it is more commonly…
Diet, exercise and Parkinson’s
A recently published large new study provides strong evidence that consuming a healthy diet and engaging in physical activity may improve outcomes for people with Parkinson’s.
World Health Organisation (WHO) launches global strategy for Parkinson’s
The WHO have published a technical brief entitled Parkinson disease: a public health approach, outlining the global burden, treatment gaps and crucial areas for intervention in Parkinson’s.
A sub-study of azathioprine in Parkinson’s
There is increasing evidence that inflammation and the immune system might have contributory roles in the development and progression of Parkinson’s.